Filing Details
- Accession Number:
- 0001209191-22-062654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-23 17:11:38
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-23 17:11:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1490829 | James Jones | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-01 | 31 | $2.33 | 25,657 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 31 | $2.31 | 25,688 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-05 | 31 | $2.19 | 25,719 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-06 | 31 | $2.19 | 25,750 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-07 | 31 | $2.18 | 25,781 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-08 | 31 | $2.19 | 25,812 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-09 | 31 | $2.15 | 25,843 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-12 | 31 | $2.14 | 25,874 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-13 | 40 | $2.18 | 25,914 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-14 | 40 | $2.21 | 25,954 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 20 | $2.24 | 25,974 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-16 | 40 | $2.22 | 26,014 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-19 | 70 | $2.21 | 26,084 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-20 | 121 | $2.31 | 26,205 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-12-21 | 88 | $2.22 | 26,293 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
